BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20207545)

  • 1. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
    Rostom SA
    Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
    Rostom SA
    Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor evaluation of new polysubstituted thiazole and derived thiazolo[4, 5-d]pyrimidine systems.
    Fahmy HT; Rostom SA; Bekhit AA
    Arch Pharm (Weinheim); 2002 May; 335(5):213-22. PubMed ID: 12210778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
    Al-Saadi MS; Rostom SA; Faidallah HM
    Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationship studies of pyrazole-based heterocycles as antitumor agents.
    Farag AM; Mayhoub AS; Eldebss TM; Amr AG; Ali KA; Abdel-Hafez NA; Abdulla MM
    Arch Pharm (Weinheim); 2010 Jul; 343(7):384-96. PubMed ID: 20397210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents.
    Farag AM; Ali KA; El-Debss TM; Mayhoub AS; Amr AG; Abdel-Hafez NA; Abdulla MM
    Eur J Med Chem; 2010 Dec; 45(12):5887-98. PubMed ID: 20950898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of some pyrazolines and pyrimidines derived from polymethoxy chalcones as anticancer and antimicrobial agents.
    Rostom SA; Badr MH; Abd El Razik HA; Ashour HM; Abdel Wahab AE
    Arch Pharm (Weinheim); 2011 Sep; 344(9):572-87. PubMed ID: 21755528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
    Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
    Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity.
    El-Deeb IM; Lee SH
    Bioorg Med Chem; 2010 Jun; 18(11):3961-73. PubMed ID: 20472440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
    Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents.
    Rostom SA; Shalaby MA; El-Demellawy MA
    Eur J Med Chem; 2003; 38(11-12):959-74. PubMed ID: 14642328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
    Rostom SA; Ashour HM; Abd El Razik HA
    Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
    Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
    Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
    Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new pyrazole derivatives and their anticancer evaluation.
    Nitulescu GM; Draghici C; Missir AV
    Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity.
    Havrylyuk D; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
    J Med Chem; 2012 Oct; 55(20):8630-41. PubMed ID: 22992049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS; Faidallah HM; Rostom SA
    Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives.
    Congiu C; Onnis V; Vesci L; Castorina M; Pisano C
    Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agents.
    Almerico AM; Mingoia F; Diana P; Barraja P; Lauria A; Montalbano A; Cirrincione G; Dattolo G
    J Med Chem; 2005 Apr; 48(8):2859-66. PubMed ID: 15828824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
    El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.